Harte Hanks, Inc. (HHS) News
Follow Harte Hanks, Inc. (HHS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Harte Hanks board reaffirms Star merger after go-shop expires
Harte Hanks said the go-shop period expired, it received acquisition proposals, and its board reaffirmed the recommendation of the Star merger.
MNA | Sep 15, 2026, 08:13 PM UTC
H
Harte Hanks, Inc. (NASDAQ:HHS) Ends Go-Shop, Names Exempted Parties
Harte Hanks said its go-shop period under the Star Equity merger ended and it designated Exempted Parties after receiving Acquisition Proposals; the board has not determined any Superior Proposal.Material DetailsContext
MNA | Sep 15, 2026, 01:24 PM UTC
H
Harte Hanks Announces Expiration of "Go-Shop Period" and Designation of "Exempted Parties"
CHELMSFORD, MA / / September 15, 2026 / Harte Hanks, Inc. ("Harte Hanks" or the "Company") announced today the expiration of the "Go-Shop Period" set forth in the previously announced Agreement and Plan of Merger with St
MNA | Sep 15, 2026, 01:21 PM UTC
L
HHS - Harte Hanks Announces Expiration of "Go-Shop Period" and Designation of "Exempted Parties"
HHS - Harte Hanks Announces Expiration of "Go-Shop Period" and Designation of "Exempted Parties"
NEWS | Sep 15, 2026, 01:20 PM UTC
M
Harte Hanks to be acquired by Star Equity for $5.00/share
Harte Hanks (HHS) enters a definitive agreement to be acquired by Star Equity Holdings at $5.00 per share.
MNA | Aug 14, 2026, 12:30 PM UTC
L
Premarket gainers list led by GXAI, CURI and IVDA
A premarket movers list shows GXAI, CURI, IVDA, HLIT, OMER, FGI, BIVI, FRGT, ONDG and HHS among the top percentage gainers, with no catalyst supplied.
EQUITY | Aug 13, 2026, 09:43 AM UTC
L
AKTS PBLS HIMS Today and tomorrow, an FDA advisory committee will mull whether compounding pharmacies should be allowed to manufacture seven
AKTS PBLS HIMS Today and tomorrow, an FDA advisory committee will mull whether compounding pharmacies should be allowed to manufacture seven peptides, in particular. This could mean a clash between career FDA scientists,
REGULATION | Jul 23, 2026, 12:13 PM UTC
L
NEO - Neogenomics Reveals Settlement Of Voluntary Disclosure To OIG-HHS; Co To Pay $9,813,260 Plus Interest At A Rate Of 4.250% Per Annum Fr
NEO - Neogenomics Reveals Settlement Of Voluntary Disclosure To OIG-HHS; Co To Pay $9,813,260 Plus Interest At A Rate Of 4.250% Per Annum From January 16, 2026 To Resolve The Matter
EQUITY | Jul 20, 2026, 09:32 PM UTC